Yes, I've been watching Avita for many years... One can look at today's valuation compared to where it traded a year ago and say it is overvalued while scratching their head at how fast the stock rose. Alternatively, prior to FDA approval I spent many years scratching my head wondering why the market cap (and trading volume) was so low given Recell's amazing results. To me, it was undervalued all those years.
I invested at times and eventually took my money out as I impatiently watched the share price languish. Luckily, once I realized FDA approval was finally close by I bought back in and held (and so glad I did!). In hindsight I realized that the inflection point at the time was FDA approval. Many large investors didn't start accumulating until after that milestone was reached, which made sense because even though the tech was flawless, it took management many more years than they forecasted to get FDA approval.
